Edinburgh questionnaire in the screeningfor peripheral artery disease intype 2 diabetic patients

##plugins.themes.academic_pro.article.sidebar##

Published Oct 24, 2018
Download
pdf
Vol. 96 No. 8 (2018): Issue Aug 2018

##plugins.themes.academic_pro.article.main##

Ibtissem Oueslati
Hana Belhadj Hassen
Habib Ben Ahmed
Kahena Bouzid
Karima Khiari
Hedi Baccar
Nejib Ben Abdallah

Abstract

Aim: to analyze Edinburgh questionnaire (EQ) screening performance for peripheral artery disease (PAD) in type 2 diabetic patients.
Methods: Cross sectional study including 150 type 2 diabetic patients without PAD history. All patients responded to EQ and had peripheral pulse checkup and measurement of the ankle/brachial index (ABI). PAD was considered to be present when the ABI was ≤ 0.9
Results: Participants mean age was 57.46 ± 8.04 years and sex-ratio (men/women) was 1.3. EQ has revealed intermittent claudication in 18 patients (12%).
On examination, 42 patients (28%) had at least one weakened or abolished pulse in upper limbs. ABI has revealed the presence of PAD in 16% of patients. The EQ sensibility specificity, positive and negative predictivevalueswere 29, 91,39 and 87%, respectively. Among patients with false negative results (n=17), nine had peripheral neuropathy.
Conclusion:In diabetic patients, EQ had a very low sensibility for the PAD screening. In fact, the important false negative rate, due to the coexisting of peripheral neuropathy, had limited the use of this questionnaire.

Keywords:

type 2 diabetes ; peripheralarterydisease ; intermittent claudication ; Edinburgh questionnaire.

##plugins.themes.academic_pro.article.details##

References

  1. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26: 3333-3341
  2. Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. World J Diabetes 2015;6(7):961-9.
  3. Wattanakit K, Folsom AR, Selvin E, Weatherley BD, Pankawa JS, Brancatib FL, et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2005; 180: 389-97.
  4. Rhee SL, Guan H, Liu ZM, Cheng S, Wapadji S, Palmes P, et al. Multi-country stydy on the prevalence and clinical features of peripheral arterial disease in Asian type 2 diabetes patients at high risk of atherosclerosis. Diabetes Res ClinPract 2007; 76:82-92.
  5. Grimaldi A, Heurtier A. [Epidemiology of cardio-vascular complications of diabetes]. Diabetes Metab 1999; 25 (3):12-20.
  6. Hiatt WR. Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy. J Intern Med2002; 251: 193-206.
  7. Adler AI, BoykoEJ, AhroniJH, Smith DG. Lower-extremity amputation in diabetes Diabetes Care 1999;22:1029-1035
  8. Marso SP, Hiatt WR. Peripheral Arterial Disease in Patients With Diabetes. J Am CollCardiol. 2006;47(5):921-9.
  9. Edinburgh Claudication Questionnaire.Occas Pap R Coll Gen Pract2002; 82: 44.
  10. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull WHO 1962; 27:645-58.
  11. Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1996;1(1):65-71.
  12. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys.J ClinEpidemiol1992;45(10):1101-9.
  13. Davies JH, Richards J, Conway K, Kenkre JE, Lewis JE, Mark Williams. Primary care screening for peripheral arterial disease: a cross-sectional observational study.Br J Gen Pract2017;67(655):e103-e110.
  14. Okello S, Millard A, Owori R, Asiimwe SB, Siedner MJ, Rwebembera J et al.Prevalence of lower extremity peripheral artery disease among adult diabetes patients in southwestern Uganda.BMC CardiovascDisord2014;14:75.
  15. Hirsch AT, Hartman L, Town RJ et al. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 2008; 13: 209-15.
  16. Codjo HL, Adoukonou TA, Wanvoegbe A, Dohou H, Bankolé C, Alassani A2, Dovonou CA2, Houénassi DM[Prevalence of peripheralarterydisease among diabetics in Parakou in 2013]. Ann CardiolAngeiol2016;65(4):260-4.
  17. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, et al. Prevalence of lower-extremity disease in the US adult population > 40 years of age with and without diabetes. Diabetes Care 2004; 27:1591e7.
  18. Millan-Guerrero RO, Vasquez C, Isais-Millan S, Trujillo-Hermandez B, Caballero-Hoyos R.[Association between neuropathy and peripheral vascular insufficiency in patients with diabetes mellitus type 2]. Rev Invest Clin2011;63(6):621-9.
  19. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol1991;20:384-392.
  20. ValdivielsoP,Ramirez-Bollero J, Pérez-LópezC. Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?World J Diabetes2014; 5(5): 577-585.
  21. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Vasc Surg. 2011;54:e32-e58.
  22. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).Eur Heart J 2011;32:2851-2906.
  23. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).J VascSurg2007;45:S5-67.
  24. Potier L, Abi Khalil C, Mohammedi K, Roussel R. Use and Utility of Ankle Brachial Index in Patients with Diabetes. Eur J VascEndovascSurg 2011; 41 (1):110-6.
  25. Natsuaki C, Inoguchi T, Maeda Y, Yamada T, Sasaki S, Sonoda N et al.Association of borderline ankle-brachial index with mortality and the incidence of peripheral artery disease in diabetic patients. Atherosclerosis 2014;234(2):360-5.